| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 12 | |
| #2 | WIPO (World Intellectual Property Organization) | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Computer technology |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Therapeutic chemical compounds | |
| #3 | Syringes | |
| #4 | Medical preparations | |
| #5 | Diagnosis and surgery | |
| #6 | Peptides | |
| #7 | Healthcare informatics | |
| #8 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kaemmerer William F | 14 |
| #2 | Kaytor Michael D | 4 |
| #3 | Heisel Jennifer | 2 |
| #4 | Burright Eric | 2 |
| #5 | Ellingson Elizabeth A | 1 |
| #6 | Soykan Orhan | 1 |
| #7 | Robinson Timothy H | 1 |
| #8 | Burright Eric N | 1 |
| #9 | Brown Mark L | 1 |
| #10 | Thakker Deepak | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2010284990A1 | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity | |
| US2010114206A1 | Patient Interface Device and Therapy Delivery System | |
| US2008124379A1 | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity | |
| US2006198825A1 | Reagents, methods and systems to suppress phospholamban expression |